nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—IFNG—atherosclerosis	0.326	0.486	CbGaD
Glucosamine—MMP9—atherosclerosis	0.208	0.31	CbGaD
Glucosamine—TNF—atherosclerosis	0.136	0.204	CbGaD
Glucosamine—CYP2C19—Rosuvastatin—atherosclerosis	0.0327	0.352	CbGbCtD
Glucosamine—CYP2C19—Simvastatin—atherosclerosis	0.0304	0.327	CbGbCtD
Glucosamine—CYP2C19—Lovastatin—atherosclerosis	0.0298	0.32	CbGbCtD
Glucosamine—MMP9—middle cerebral artery—atherosclerosis	0.0165	0.233	CbGeAlD
Glucosamine—MMP9—tunica intima—atherosclerosis	0.0103	0.146	CbGeAlD
Glucosamine—MMP9—hindlimb—atherosclerosis	0.00575	0.0815	CbGeAlD
Glucosamine—MMP9—appendage—atherosclerosis	0.00493	0.0699	CbGeAlD
Glucosamine—IFNG—endothelium—atherosclerosis	0.00464	0.0657	CbGeAlD
Glucosamine—IFNG—blood vessel—atherosclerosis	0.00428	0.0606	CbGeAlD
Glucosamine—MMP9—artery—atherosclerosis	0.00353	0.0499	CbGeAlD
Glucosamine—MMP9—endothelium—atherosclerosis	0.00298	0.0422	CbGeAlD
Glucosamine—MMP9—blood vessel—atherosclerosis	0.00275	0.0389	CbGeAlD
Glucosamine—NFKB2—adipose tissue—atherosclerosis	0.00248	0.0352	CbGeAlD
Glucosamine—IFNG—connective tissue—atherosclerosis	0.00219	0.0311	CbGeAlD
Glucosamine—IFNG—cardiovascular system—atherosclerosis	0.00191	0.027	CbGeAlD
Glucosamine—NFKB2—liver—atherosclerosis	0.00174	0.0247	CbGeAlD
Glucosamine—MMP9—connective tissue—atherosclerosis	0.00141	0.0199	CbGeAlD
Glucosamine—MMP9—cardiovascular system—atherosclerosis	0.00123	0.0174	CbGeAlD
Glucosamine—IFNG—liver—atherosclerosis	0.00118	0.0167	CbGeAlD
Glucosamine—MMP9—adipose tissue—atherosclerosis	0.00108	0.0153	CbGeAlD
Glucosamine—MMP9—liver—atherosclerosis	0.000758	0.0107	CbGeAlD
Glucosamine—CYP2E1—cardiovascular system—atherosclerosis	0.000404	0.00572	CbGeAlD
Glucosamine—CYP2C19—liver—atherosclerosis	0.00034	0.00481	CbGeAlD
Glucosamine—CYP2E1—liver—atherosclerosis	0.00025	0.00354	CbGeAlD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	1.93e-05	0.000115	CbGpPWpGaD
Glucosamine—IFNG—Immune System—AGER—atherosclerosis	1.92e-05	0.000115	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PRKCG—atherosclerosis	1.9e-05	0.000114	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ICAM1—atherosclerosis	1.9e-05	0.000114	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CX3CR1—atherosclerosis	1.9e-05	0.000114	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CASR—atherosclerosis	1.9e-05	0.000114	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	1.88e-05	0.000113	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—GSTM1—atherosclerosis	1.88e-05	0.000113	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL6—atherosclerosis	1.87e-05	0.000112	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CX3CL1—atherosclerosis	1.86e-05	0.000111	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD36—atherosclerosis	1.86e-05	0.000111	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—GSTM1—atherosclerosis	1.85e-05	0.000111	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.85e-05	0.000111	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—VEGFA—atherosclerosis	1.83e-05	0.000109	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	1.81e-05	0.000109	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	1.81e-05	0.000109	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—AKT1—atherosclerosis	1.8e-05	0.000108	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—MAPK3—atherosclerosis	1.79e-05	0.000107	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	1.78e-05	0.000107	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—MAPK3—atherosclerosis	1.77e-05	0.000106	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—LPL—atherosclerosis	1.76e-05	0.000106	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CNR2—atherosclerosis	1.76e-05	0.000106	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	1.75e-05	0.000105	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TGFB1—atherosclerosis	1.74e-05	0.000104	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL6—atherosclerosis	1.74e-05	0.000104	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—MAPK3—atherosclerosis	1.73e-05	0.000104	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—LDLRAP1—atherosclerosis	1.73e-05	0.000103	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PDGFB—atherosclerosis	1.71e-05	0.000103	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.71e-05	0.000102	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CD36—atherosclerosis	1.68e-05	0.0001	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CRP—atherosclerosis	1.68e-05	0.0001	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PLTP—atherosclerosis	1.62e-05	9.72e-05	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.62e-05	9.68e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	1.61e-05	9.67e-05	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IL6—atherosclerosis	1.61e-05	9.62e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TLR4—atherosclerosis	1.61e-05	9.62e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—VWF—atherosclerosis	1.57e-05	9.41e-05	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.57e-05	9.39e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—APOC3—atherosclerosis	1.56e-05	9.35e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—PPARA—atherosclerosis	1.56e-05	9.34e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—LDLR—atherosclerosis	1.55e-05	9.29e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ICAM1—atherosclerosis	1.54e-05	9.23e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	1.53e-05	9.17e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	1.53e-05	9.17e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	1.53e-05	9.17e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	1.53e-05	9.17e-05	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL6—atherosclerosis	1.52e-05	9.12e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL3—atherosclerosis	1.52e-05	9.08e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	1.51e-05	9.06e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—LEP—atherosclerosis	1.48e-05	8.86e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	1.46e-05	8.75e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NCF1—atherosclerosis	1.45e-05	8.69e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IFNG—atherosclerosis	1.45e-05	8.66e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—NFKB1—atherosclerosis	1.44e-05	8.61e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—LTA4H—atherosclerosis	1.41e-05	8.43e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ABCG8—atherosclerosis	1.41e-05	8.43e-05	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—AKT1—atherosclerosis	1.4e-05	8.42e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	1.4e-05	8.39e-05	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL6—atherosclerosis	1.39e-05	8.32e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCR2—atherosclerosis	1.37e-05	8.21e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EDNRA—atherosclerosis	1.37e-05	8.21e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CYBA—atherosclerosis	1.36e-05	8.17e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	1.35e-05	8.07e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GHRL—atherosclerosis	1.34e-05	8e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PARP1—atherosclerosis	1.34e-05	8e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PLAT—atherosclerosis	1.34e-05	8e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—LDLRAP1—atherosclerosis	1.33e-05	7.98e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—VEGFA—atherosclerosis	1.3e-05	7.81e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	1.3e-05	7.8e-05	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—IL6—atherosclerosis	1.3e-05	7.77e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—STAT3—atherosclerosis	1.29e-05	7.73e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL1B—atherosclerosis	1.29e-05	7.73e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—PPARG—atherosclerosis	1.29e-05	7.72e-05	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—AKT1—atherosclerosis	1.29e-05	7.71e-05	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—IL6—atherosclerosis	1.26e-05	7.57e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—INS—atherosclerosis	1.26e-05	7.57e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PLTP—atherosclerosis	1.25e-05	7.5e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—MAPK3—atherosclerosis	1.23e-05	7.39e-05	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—AKT1—atherosclerosis	1.21e-05	7.23e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—NFKB1—atherosclerosis	1.2e-05	7.21e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TGFB1—atherosclerosis	1.2e-05	7.17e-05	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—AKT1—atherosclerosis	1.2e-05	7.17e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—MAPK8—atherosclerosis	1.18e-05	7.09e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MMP2—atherosclerosis	1.18e-05	7.09e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—KNG1—atherosclerosis	1.17e-05	7.02e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—AGTR1—atherosclerosis	1.17e-05	6.98e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	1.16e-05	6.95e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	1.15e-05	6.91e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	1.15e-05	6.86e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PLG—atherosclerosis	1.14e-05	6.8e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.12e-05	6.7e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TNF—atherosclerosis	1.12e-05	6.69e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ABCG1—atherosclerosis	1.11e-05	6.66e-05	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.09e-05	6.53e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—LTA4H—atherosclerosis	1.09e-05	6.5e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ABCG8—atherosclerosis	1.09e-05	6.5e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—STAT3—atherosclerosis	1.08e-05	6.48e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SOCS3—atherosclerosis	1.08e-05	6.44e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.07e-05	6.42e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—FABP4—atherosclerosis	1.05e-05	6.26e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—LCAT—atherosclerosis	1.05e-05	6.26e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL1B—atherosclerosis	1.05e-05	6.26e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MMP3—atherosclerosis	1.04e-05	6.22e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IGF2—atherosclerosis	1.03e-05	6.19e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—MAPK3—atherosclerosis	1.03e-05	6.19e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—APOA4—atherosclerosis	1.03e-05	6.15e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.01e-05	6.06e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP7A1—atherosclerosis	1.01e-05	6.04e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—APOB—atherosclerosis	1e-05	6.01e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EDN1—atherosclerosis	9.88e-06	5.92e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL5—atherosclerosis	9.8e-06	5.87e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NFKB1—atherosclerosis	9.75e-06	5.84e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MAPK8—atherosclerosis	9.58e-06	5.74e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—LPL—atherosclerosis	9.58e-06	5.74e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP27A1—atherosclerosis	9.32e-06	5.58e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PRKCG—atherosclerosis	9.32e-06	5.58e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SPP1—atherosclerosis	9.08e-06	5.44e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	9.02e-06	5.4e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6—atherosclerosis	9.02e-06	5.4e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MMP9—atherosclerosis	8.89e-06	5.33e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PLA2G2A—atherosclerosis	8.83e-06	5.29e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—APOA2—atherosclerosis	8.83e-06	5.29e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALOX15—atherosclerosis	8.83e-06	5.29e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALOX5AP—atherosclerosis	8.83e-06	5.29e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—NFKB1—atherosclerosis	8.8e-06	5.27e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—STAT3—atherosclerosis	8.76e-06	5.25e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ABCG5—atherosclerosis	8.73e-06	5.23e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ABCG1—atherosclerosis	8.58e-06	5.14e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—LPA—atherosclerosis	8.43e-06	5.05e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PDGFB—atherosclerosis	8.4e-06	5.03e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MAPK3—atherosclerosis	8.37e-06	5.02e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—AKT1—atherosclerosis	8.32e-06	4.98e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—AGT—atherosclerosis	8.2e-06	4.91e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—BGN—atherosclerosis	8.16e-06	4.89e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—APOA5—atherosclerosis	8.08e-06	4.84e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—FABP4—atherosclerosis	8.07e-06	4.83e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—LCAT—atherosclerosis	8.07e-06	4.83e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—LEP—atherosclerosis	8.03e-06	4.81e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—APOE—atherosclerosis	8.03e-06	4.81e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—VEGFA—atherosclerosis	7.98e-06	4.78e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CAV1—atherosclerosis	7.96e-06	4.77e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—APOA1—atherosclerosis	7.94e-06	4.76e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—APOA4—atherosclerosis	7.92e-06	4.74e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—STAT3—atherosclerosis	7.9e-06	4.74e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP7A1—atherosclerosis	7.78e-06	4.66e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PLA2G1B—atherosclerosis	7.78e-06	4.66e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ESR1—atherosclerosis	7.67e-06	4.6e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—F2—atherosclerosis	7.58e-06	4.54e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6—atherosclerosis	7.55e-06	4.53e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MAPK3—atherosclerosis	7.55e-06	4.52e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALOX5—atherosclerosis	7.51e-06	4.5e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	7.41e-06	4.44e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—TGFB1—atherosclerosis	7.33e-06	4.39e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PIK3CG—atherosclerosis	7.25e-06	4.34e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP27A1—atherosclerosis	7.19e-06	4.31e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	7.08e-06	4.24e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—AKT1—atherosclerosis	6.97e-06	4.18e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.91e-06	4.14e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—INS—atherosclerosis	6.86e-06	4.11e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	6.82e-06	4.08e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	6.82e-06	4.08e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALOX15—atherosclerosis	6.82e-06	4.08e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—APOA2—atherosclerosis	6.82e-06	4.08e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL2—atherosclerosis	6.75e-06	4.05e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NAMPT—atherosclerosis	6.74e-06	4.04e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ABCG5—atherosclerosis	6.73e-06	4.03e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.73e-06	4.03e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—LIPC—atherosclerosis	6.7e-06	4.01e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—APOC3—atherosclerosis	6.65e-06	3.99e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IGF1—atherosclerosis	6.64e-06	3.98e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—LDLR—atherosclerosis	6.61e-06	3.96e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—LPA—atherosclerosis	6.5e-06	3.9e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CETP—atherosclerosis	6.46e-06	3.87e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SERPINE1—atherosclerosis	6.3e-06	3.78e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—BGN—atherosclerosis	6.3e-06	3.77e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.25e-06	3.75e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—APOA5—atherosclerosis	6.23e-06	3.73e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SCARB1—atherosclerosis	6.19e-06	3.71e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6—atherosclerosis	6.12e-06	3.67e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.06e-06	3.63e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NOS3—atherosclerosis	6.02e-06	3.61e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	6e-06	3.6e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.93e-06	3.55e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.88e-06	3.52e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.87e-06	3.51e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—HMGCR—atherosclerosis	5.84e-06	3.5e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALOX5—atherosclerosis	5.8e-06	3.47e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—AKT1—atherosclerosis	5.65e-06	3.38e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6—atherosclerosis	5.52e-06	3.31e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.35e-06	3.21e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL8—atherosclerosis	5.34e-06	3.2e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ABCA1—atherosclerosis	5.21e-06	3.12e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NAMPT—atherosclerosis	5.2e-06	3.11e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.17e-06	3.1e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—LIPC—atherosclerosis	5.17e-06	3.09e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—APOC3—atherosclerosis	5.13e-06	3.08e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—LDLR—atherosclerosis	5.1e-06	3.06e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—AKT1—atherosclerosis	5.09e-06	3.05e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CETP—atherosclerosis	4.98e-06	2.99e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NFKB1—atherosclerosis	4.78e-06	2.86e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SCARB1—atherosclerosis	4.77e-06	2.86e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MAPK8—atherosclerosis	4.7e-06	2.81e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.65e-06	2.78e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—HMGCR—atherosclerosis	4.51e-06	2.7e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—HMOX1—atherosclerosis	4.47e-06	2.68e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—VEGFA—atherosclerosis	4.34e-06	2.6e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—STAT3—atherosclerosis	4.29e-06	2.57e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—APOB—atherosclerosis	4.28e-06	2.56e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GSTM1—atherosclerosis	4.16e-06	2.49e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MAPK3—atherosclerosis	4.1e-06	2.46e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—LPL—atherosclerosis	4.09e-06	2.45e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.07e-06	2.44e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ABCA1—atherosclerosis	4.02e-06	2.41e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GPX1—atherosclerosis	3.99e-06	2.39e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TGFB1—atherosclerosis	3.98e-06	2.38e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CD36—atherosclerosis	3.88e-06	2.33e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—MTHFR—atherosclerosis	3.68e-06	2.2e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PPARA—atherosclerosis	3.61e-06	2.16e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—AGT—atherosclerosis	3.5e-06	2.09e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—HMOX1—atherosclerosis	3.45e-06	2.06e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—APOE—atherosclerosis	3.42e-06	2.05e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CAV1—atherosclerosis	3.39e-06	2.03e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—APOA1—atherosclerosis	3.39e-06	2.03e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—APOB—atherosclerosis	3.3e-06	1.98e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GSTM1—atherosclerosis	3.21e-06	1.92e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—LPL—atherosclerosis	3.15e-06	1.89e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PIK3CG—atherosclerosis	3.09e-06	1.85e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GPX1—atherosclerosis	3.08e-06	1.84e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6—atherosclerosis	3e-06	1.8e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CD36—atherosclerosis	3e-06	1.79e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PPARG—atherosclerosis	2.98e-06	1.79e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—INS—atherosclerosis	2.93e-06	1.75e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—MTHFR—atherosclerosis	2.84e-06	1.7e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PPARA—atherosclerosis	2.78e-06	1.67e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—AKT1—atherosclerosis	2.77e-06	1.66e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—AGT—atherosclerosis	2.7e-06	1.62e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALB—atherosclerosis	2.68e-06	1.61e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—APOE—atherosclerosis	2.64e-06	1.58e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CAV1—atherosclerosis	2.62e-06	1.57e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—APOA1—atherosclerosis	2.61e-06	1.56e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NOS3—atherosclerosis	2.57e-06	1.54e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	2.38e-06	1.43e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTGS2—atherosclerosis	2.35e-06	1.41e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PPARG—atherosclerosis	2.3e-06	1.38e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—INS—atherosclerosis	2.26e-06	1.35e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALB—atherosclerosis	2.07e-06	1.24e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NOS3—atherosclerosis	1.98e-06	1.19e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTGS2—atherosclerosis	1.81e-06	1.08e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—AKT1—atherosclerosis	1.18e-06	7.07e-06	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—AKT1—atherosclerosis	9.1e-07	5.45e-06	CbGpPWpGaD
